课题基金 / 基金详情

Mechanism of Respiratory Syncytial Virus Fusion

Mechanism of Respiratory Syncytial Virus Fusion
呼吸道合胞病毒融合机制
批准号:
8415506
负责人:
Mark E. Peeples
金额:
$34.03万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-01 至 2017-01-31

项目摘要

项目成果

Mark E. Peeples的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):呼吸道合胞病毒(RSV)感染仍然是婴儿和老年人的重要医学问题。感染需要病毒膜与靶细胞膜融合,从而将病毒基因组传递到靶细胞质中。病毒融合蛋白(F),三种RSV糖蛋白之一,执行这一作用。它
英文摘要
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) infection remains an important medical problem for infants and the elderly. Infection requires the fusion of the vira membrane with the target cell membrane, which delivers the viral genome into the target cell cytoplasm. The viral fusion (F) protein, one of the three RSV glycoproteins, performs this role. It is clear from the crystal structures of two related viruses, one in the pre-triggered and one in th post-triggered form, that the F protein undergoes massive changes in structure to accomplish membrane fusion. Based on these structures, models of the pre-triggered and post-triggered RSV F protein have been generated. Using the pre-triggered model, the most likely sites for attachment to target cells and/or for triggering have been identified. Mutation of the amino acids in these sites to alanine will test their importance in cell-cell fusion. Mutations that prevent fuion without preventing the F protein from reaching the cell surface will be studied biochemically for their attachment and triggering abilities. For these studies, a soluble (sF) version of the F proten in its pre-triggered form has been produced for the first time, and shown to be triggered by a reduction in molarity. The possibility that reduced molarity causes F protein triggering will also be investigated since its mechanism may provide novel antiviral drug targets. Overall, these studies will result in the identification of functional domains in the F protein that can be used t rapidly screen for novel antiviral compounds and to develop novel vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
Mechanism of Respiratory Syncytial Virus Fusion
Mechanism of Respiratory Syncytial Virus Fusion
Mechanism of Respiratory Syncytial Virus Fusion
海外基金